High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements
スポンサーリンク
概要
- 論文の詳細を見る
- 1997-12-05
著者
-
BUCLIN T.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
BIOLLAZ J.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
DECOSTERD L.
Division de Pharmacologie Clinique, Laboratoire BH 18-218, Department de Medicine, Centre Hospitalie
-
Buclin T.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Karagiannis A.
Division D'hypertension Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Biollaz J.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
ROULET J.-M.
Institut de Chimie Organique, Faculte des Sciences, Universite de Lausanne
-
BELAZ N.
Division de Pharmacologie Clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
APPENZELLER M.
Division de Pharmacologie Clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
VOGEL P.
Institut de Chimie Organique, Faculte des Sciences, Universite de Lausanne
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Belaz N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois 1
-
Roulet J.-m.
Institut De Chimie Organique Faculte Des Sciences Universite De Lausanne
-
Appenzeller M.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois 1
-
Vogel P.
Institut De Chimie Organique Faculte Des Sciences Universite De Lausanne
関連論文
- Determination of imatinib (Gleevec^【○!R】) in human plasma by solid-phase extraction-liquid chromatography-ultraviolet absorbance detection
- Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry
- Determination of aciclovir and ganciclovir in human plasma by liquid chromatography-spectrofluorimetric detection and stability studies in blood samples
- Determination of the novel non-peptidic HIV-protease inhibitor tipranavir by HPLC-UV after solid-phase extraction
- Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction
- High-performance liquid chromatography of the renal blood flow marker p-aminohippuric acid (PAH) and its metabolite N-acetyl PAH improves PAH clearance measurements
- Determination of temozolomide in human plasma and urine by high-performance liquid chromatography after solid-phase extraction
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
- A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents : Raltegravir, maraviroc, darunavir, and etravirine
- An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma : First evidence of 4'-hydroxylated metabolites in breast cancer patients
- A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma